[Stellar Pharmaceuticals-KY] April 2026 Revenue 0.02 Billion (Year-on-Year Decrease of -57.1%)
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Stellar Pharmaceuticals-KY announced its April 2026 revenue of NT$1.668 million, a significant decrease of 57.1% compared to the previous year. The company operates in the biotechnology and healthcare industry.